A global medical device manufacturing company specializing in the development, production, and worldwide supply of diverse bio-signal measurement devices, including electrocardiographs, patient monitors, fetal heart monitors, heart rate monitors, and cardiopulmonary measurement devices.Aglobalmedicaldevicemanufacturingcompanyspecializinginthedevelopment,production,andworldwidesupplyofdiversebio-signalmeasurementdevices,includingelectrocardiographs,patientmonitors,fetalheartmonitors,heartratemonitors,andcardiopulmonarymeasurementdevices.
Key Products/TechnologiesKeyProducts/Technologies
Electrocardiographs (ECG/EKG): A diverse range of models such as CardioXP, Cardio7, CardioCare2000, CardioTouch3000, and Cardio Q Series.Electrocardiographs(ECG/EKG):AdiverserangeofmodelssuchasCardioXP,Cardio7,CardioCare2000,CardioTouch3000,andCardioQSeries.
Patient Monitors: A comprehensive lineup including BM7, BM5, BM3, BM1, BM Central, and Brio X Series. Real-time measurement and display technology for essential bio-signals like ECG, SpO2, NIBP, respiration, and temperature in various medical settings. Modular design for scalability and wired/wireless network functionality for central monitoring system integration.PatientMonitors:AcomprehensivelineupincludingBM7,BM5,BM3,BM1,BMCentral,andBrioXSeries.Real-timemeasurementanddisplaytechnologyforessentialbio-signalslikeECG,SpO2,NIBP,respiration,andtemperatureinvariousmedicalsettings.Modulardesignforscalabilityandwired/wirelessnetworkfunctionalityforcentralmonitoringsystemintegration.
Fetal Monitors: Development and production capabilities for fetal heart sound and heart rate monitoring equipment.FetalMonitors:Developmentandproductioncapabilitiesforfetalheartsoundandheartratemonitoringequipment.
Spirometers: Models combined with ECG like CardioXP-S, Cardio7-S, CardioTouch3000S, and diagnostic spirometers (SPM-7). Technology for accurate and infection-free spirometry measurements.Spirometers:ModelscombinedwithECGlikeCardioXP-S,Cardio7-S,CardioTouch3000S,anddiagnosticspirometers(SPM-7).Technologyforaccurateandinfection-freespirometrymeasurements.
Veterinary Equipment: Solutions for animal healthcare including veterinary monitors (BM1Vet, VEMO, VEMO Plus), capnography devices, pulse oximeters, dental X-ray systems, and SonoMe Vet.VeterinaryEquipment:Solutionsforanimalhealthcareincludingveterinarymonitors(BM1Vet,VEMO,VEMOPlus),capnographydevices,pulseoximeters,dentalX-raysystems,andSonoMeVet.
Ultrasound Imaging Diagnostic Devices: Development of portable and personal tablet ultrasound scanners such as MU1, MU1V, and wireless ultrasound (SonoMe).UltrasoundImagingDiagnosticDevices:DevelopmentofportableandpersonaltabletultrasoundscannerssuchasMU1,MU1V,andwirelessultrasound(SonoMe).
Others: Hand-held oximeters (Oxy9Wave), Pocket Doppler, infusion pumps (PION TCI, PION Syringe), 24-hour signal recorders (CH-100), blood pressure monitors (ABP Lab24), and other diverse medical device offerings.Others:Hand-heldoximeters(Oxy9Wave),PocketDoppler,infusionpumps(PIONTCI,PIONSyringe),24-hoursignalrecorders(CH-100),bloodpressuremonitors(ABPLab24),andotherdiversemedicaldeviceofferings.
Core Technologies: Bio-signal processing technology, capabilities for building U-healthcare systems based on wired/wireless networks, and ongoing development of AI-based healthcare solutions.CoreTechnologies:Bio-signalprocessingtechnology,capabilitiesforbuildingU-healthcaresystemsbasedonwired/wirelessnetworks,andongoingdevelopmentofAI-basedhealthcaresolutions.
Core AdvantagesCoreAdvantages
Global Production and Sales Network: Operation of three overseas subsidiaries (MGB Berlin in Germany, Bionet America, Bionet Latin America) centered around the Seoul headquarters, with a global market presence through over 100 partner distributors in 80 countries.GlobalProductionandSalesNetwork:Operationofthreeoverseassubsidiaries(MGBBerlininGermany,BionetAmerica,BionetLatinAmerica)centeredaroundtheSeoulheadquarters,withaglobalmarketpresencethroughover100partnerdistributorsin80countries.
Extensive Product Portfolio: Provision of comprehensive solutions encompassing various bio-signal medical devices like ECG, patient monitors, fetal monitors, and spirometers, as well as veterinary equipment and ultrasound imaging diagnostic devices.ExtensiveProductPortfolio:Provisionofcomprehensivesolutionsencompassingvariousbio-signalmedicaldeviceslikeECG,patientmonitors,fetalmonitors,andspirometers,aswellasveterinaryequipmentandultrasoundimagingdiagnosticdevices.
R&D-Oriented Innovation Capability: A significant portion of employees (35%) dedicated to R&D, operating four research institutes (Healthcare, Intensive Care (IC), Point of Care (POC), Endoscopy (Endo)) for continuous technological advancement and new technology acquisition.R&D-OrientedInnovationCapability:Asignificantportionofemployees(35%)dedicatedtoR&D,operatingfourresearchinstitutes(Healthcare,IntensiveCare(IC),PointofCare(POC),Endoscopy(Endo))forcontinuoustechnologicaladvancementandnewtechnologyacquisition.
Technological Prowess and Quality Stability: Possession of proprietary bio-signal processing technology and numerous patents, coupled with international quality certifications such as FDA, ISO 9001, ISO 13485, and EU CE MDR for high reliability.TechnologicalProwessandQualityStability:Possessionofproprietarybio-signalprocessingtechnologyandnumerouspatents,coupledwithinternationalqualitycertificationssuchasFDA,ISO9001,ISO13485,andEUCEMDRforhighreliability.
Expansion into Digital Healthcare and AI-based Solutions: Business expansion into 'Connected Healthcare' solutions integrating wireless and network technologies, with plans to offer AI-powered healthcare solutions.ExpansionintoDigitalHealthcareandAI-basedSolutions:Businessexpansioninto'ConnectedHealthcare'solutionsintegratingwirelessandnetworktechnologies,withplanstoofferAI-poweredhealthcaresolutions.
Cost-Effective and Innovative Technology Provision: Development of products designed to enhance the ease, speed, and economical aspects of patient care, alongside competitive pricing.Cost-EffectiveandInnovativeTechnologyProvision:Developmentofproductsdesignedtoenhancetheease,speed,andeconomicalaspectsofpatientcare,alongsidecompetitivepricing.
Target IndustrieTargetIndustrie
General Hospitals and Clinics: Provision of patient monitoring and diagnostic solutions in various medical environments including operating rooms, intensive care units, emergency rooms, and wards.GeneralHospitalsandClinics:Provisionofpatientmonitoringanddiagnosticsolutionsinvariousmedicalenvironmentsincludingoperatingrooms,intensivecareunits,emergencyrooms,andwards.
Private Clinics: Supply of basic bio-signal diagnosis and management equipment for ECG and spirometry.PrivateClinics:Supplyofbasicbio-signaldiagnosisandmanagementequipmentforECGandspirometry.
Veterinary Hospitals and Clinics: Application in veterinary fields for animal patient monitoring and diagnostic imaging equipment.VeterinaryHospitalsandClinics:Applicationinveterinaryfieldsforanimalpatientmonitoringanddiagnosticimagingequipment.
Home and Remote Healthcare Settings: Implementation of patient self-diagnosis and remote monitoring services through U-healthcare systems.HomeandRemoteHealthcareSettings:Implementationofpatientself-diagnosisandremotemonitoringservicesthroughU-healthcaresystems.
Major MarketsMajorMarkets
African regionAfricanregion
South Korea, Indonesia, Taiwan, Middle-East regions, CIS NationsSouthKorea,Indonesia,Taiwan,Middle-Eastregions,CISNations
Germany, Poland, European countriesGermany,Poland,Europeancountries
United States, CanadaUnitedStates,Canada
Oceania regionOceaniaregion
Latin AmericaLatinAmerica
Certifications/PatentsCertifications/Patents
Certifications: International standard quality certifications including ISO 13485, FDA, EU CE (for Cardio 7, Cardio P1, Brio X30, Brio X50, Brio X70), and ISO 9001.Certifications:InternationalstandardqualitycertificationsincludingISO13485,FDA,EUCE(forCardio7,CardioP1,BrioX30,BrioX50,BrioX70),andISO9001.
Patents: Ownership of 61 patents.Patents:Ownershipof61patents.
Awards: Selection as a 'Hi Seoul Company' certified as an excellent company by Seoul City in 2023, and receipt of the Minister of Trade, Industry and Energy Award at KIMES 2023.Awards:Selectionasa'HiSeoulCompany'certifiedasanexcellentcompanybySeoulCityin2023,andreceiptoftheMinisterofTrade,IndustryandEnergyAwardatKIMES2023.
Technological Strengths: Accumulation of technological expertise in medical device development, production, and sales based on bio-signal technology.TechnologicalStrengths:Accumulationoftechnologicalexpertiseinmedicaldevicedevelopment,production,andsalesbasedonbio-signaltechnology.